Gujarat Kidney revenue doubles to ₹82 cr after Parekhs acquisition
Consolidated revenue climbed to ₹82.01 crore in FY26, up from ₹40.24 crore, as the hospital operator integrated Parekhs Hospital into its results.
— 1 earlier story on Gujarat Kidney And Super Speciality Ltd. →What's new
- Revenue more than doubled to ₹82.01 crore following the Parekhs Hospital acquisition.
- Net profit rose to ₹16.81 crore from ₹9.50 crore in the previous fiscal year.
- The board is seeking shareholder approval via postal ballot to change how it uses IPO proceeds.
Why this matters
The jump in top-line performance is a direct result of inorganic expansion. The market had already priced in the acquisition and the deployment of IPO funds. Deferring the CEO appointment suggests internal leadership transitions remain a work in progress.
What we're watching
- Shareholder response to the proposed change in IPO fund utilization.
- Updates on the deferred chief executive appointment.
- Whether the expanded balance sheet of ₹298 crore yields further margin improvements.
The full read
Gujarat Kidney And Super Speciality Ltd reported a sharp expansion in its financial footprint for FY26. Consolidated revenue reached ₹82.01 crore, more than doubling from the ₹40.24 crore recorded in the previous year. Net profit followed suit, rising to ₹16.81 crore from ₹9.50 crore. The company’s balance sheet now stands at ₹298 crore, a fivefold increase attributed to the acquisition of Parekhs Hospital and the deployment of IPO capital.
Leadership is in flux.
The board deferred the appointment of a new chief executive. Also, the company is asking shareholders to approve a change in the use of its IPO proceeds via a postal ballot. The growth was largely anticipated by the market, given the prior disclosure of the hospital acquisition. The next test is whether the company can maintain these margins while working through the shift in its capital allocation strategy.
Questions answered
- What drove the revenue growth for Gujarat Kidney in FY26?
- The primary driver was the consolidation of Parekhs Hospital into the company's financial results. This acquisition helped push annual revenue to ₹82.01 crore.
- How did the company's profitability change?
- Net profit reached ₹16.81 crore for the fiscal year ended March 31, 2026. This is an increase from the ₹9.50 crore reported in the prior year.
- Why is the company seeking a postal ballot?
- The board intends to vary the original objects of its IPO proceeds. It requires shareholder approval to change how these funds are utilized.
- What is the status of the company's leadership?
- The board has deferred the appointment of a new chief executive. No new timeline for the selection was provided in the filing.
Story so far
All notes on GKSL →- 29 May 2026 · 2:55 PM IST Gujarat Kidney revenue doubles to ₹82 cr after Parekhs acquisition
- 1d ago Gujarat Kidney revenue hits ₹82 cr after Parekhs Hospital acquisition